XXII (22nd Century Group) 5-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XXII 22nd Century Group Inc XXII
18 GF Score
Price $1.68
! 6 Warning Signs
View Full Analysis

What is 22nd Century Group 5-Year EBITDA Growth Rate?

22nd Century Group XXII -4.55% 18 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates XXII with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

22nd Century Group's EBITDA per Share for the three months ended in Jun. 2026 was $-14.33.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

22nd Century Group  (NAS:XXII) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

22nd Century Group 5-Year EBITDA Growth Rate Related Terms

XXII vs GNLN, LIFD, ECGS: 5-Year EBITDA Growth Rate Comparison

For the Tobacco subindustry, 22nd Century Group's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

22nd Century Group 5-Year EBITDA Growth Rate vs Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, 22nd Century Group's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where 22nd Century Group's 5-Year EBITDA Growth Rate falls into.


XXII
18GF Score
22nd Century Group Inc XXII
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

22nd Century Group 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
22nd Century Group (XXII) has a 5-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for 22nd Century Group and its competitors.
Is 22nd Century Group's 5-Year EBITDA Growth Rate too high?
22nd Century Group's current 5-Year EBITDA Growth Rate is 0.00%. Overall, 22nd Century Group has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does 22nd Century Group's 5-Year EBITDA Growth Rate compare to GNLN and LIFD?
22nd Century Group's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Tobacco Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Tobacco Products company?
A good 5-Year EBITDA Growth Rate depends on the Tobacco Products industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for 22nd Century Group and its competitors. 22nd Century Group's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 22nd Century Group stock overvalued right now?
22nd Century Group (XXII) has a current 5-Year EBITDA Growth Rate of 0.00%. The current 5-Year EBITDA Growth Rate is 0.00%. 22nd Century Group's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For 22nd Century Group (XXII), the current 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

22nd Century Group Business Description

Address 321 Farmington Road, Mocksville, NC, USA, 27028
22nd Century Group Inc is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The company manufactures and distributes the only combustible tobacco products containing minimally or non-addictive levels of nicotine. The Company has organized its business as a single reportable segment: tobacco, as it operates and derives all revenues from its tobacco operations and products.
18GF Score

Get the complete analysis for XXII

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.68
Price